Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 2154
Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Access to Global Online Research in Agriculture (AGORA)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Adjuvant potential of outer membrane vesicles from Neisseria lactamica
Biotechnology World Convention
Mariana Watanabe Garcia
University of São Paulo, Brazil Instituto Butantan, Brazil
ScientificTracks Abstracts: J Biotechnol Biomater
Abstract
Outer membrane vesicles or OMVs are derived from evaginations of Gram-negative bacteria outer membrane and they have gained immunological interest especially in relation to their ability to modulate biological functions and to be an alternative to the development of new vaccine strategies and combinations thereof. OMVs from commensal bacterium Neisseria lactamica induce antibodies which have cross reactivity with N. meningitidis and may be both antigen to meningococcal disease and a potential mucosal adjuvant. The objective of this study was to evaluate the adjuvant function of Neisseria lactamica OMVs using the surface protein PspA5 from Streptococcus pneumoniae as antigen model. OMVs were obtained from cultivations of the bacteria in bench scale bioreactor. The immunoassays were performed with OMVs in natura formulation (pure) and OMVs purified with sodium deoxycholate (DOC) at 0.3% and 0.5% in order to remove part of its lipopolysaccharide (LOS). The immunization groups were divided into 5 control groups: (1) Non, (2) PspA5, (3) pure OMV (OMVpure), (4) OMV purified with DOC 0.3% (OMV0.3%), (5) OMV purified with DOC 0.5% (OMV0.5%) and 3 vaccinated groups: (6) PspA5 in combination with OMVpure, (7) PspA5 in combination with OMV0.3% and (8) PspA5 in combination with OMV0.5%. The schedule set 2 intranasal fortnightly doses in murine model. It was evaluated the induction of anti-PspA5 IgG antibodies (IgG, IgG1 and IgG2a) and the protective potential of the different formulation. Initial immunological tests showed determinant adjuvant activity of all OMVs using the heterologous protein PspA5 as antigen model and protection against survival challenge.Biography
Mariana Watanabe Garcia is Biological Scientist who graduated from Mackenzie University (2011). She was honored to have been the best student of Biological Sciences from 2008 to 2011. She is completing her PhD in Biotechnology from University of São Paulo in a project that has been developed in partnership with Butantan Institute, Brazil. She is also working at Merck Life Science as Biotechnology Application Specialist.
Email: mariana_watanabe@hotmail.com
